Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Nelson Obus’ Wynnefield Capital Reported 25% Activist Stake In $MAMS

Nelson Obus’ Wynnefield Capital reported its 25% activist stake in Mam Software Group, Inc. (MAMS) after the firm sold 175 thousand shares in the stock at about $1.65 per share on December 23rd, according to the firm’s most recent insider trading filing. Wynnefield Capital initially filed its MAMS position in March 2008. Now the stock is priced at $1.75.

According to the firm’s official bio, Wynnefield Capital, Inc. “is a value investor, specializing in U.S. small cap situations that have a company or industry specific catalyst. Surfacing of these catalysts unlocks existing, but previously unrecognized value for shareholders. WCI maintains an active investment philosophy.” The firm reported a 13F portfolio of $236 million, increasing by 0.87% from the second quarter. It mainly invests in Healthcare, Services, Consumer Goods, Industrial Goods, and Financial sector.

According to Google Finance, MAM Software Group, Inc. “formerly Aftersoft Group, Inc. provides software, information and related services to businesses engaged in the automotive aftermarket in the United States, Canada, the United Kingdom and Ireland. The company’s business management systems, information products and online services permit its customers to manage their critical day-to-day business operations through automated point-of-sale, information products, inventory management, purchasing, general accounting and customer relationship management.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!